NOX4 is the main NADPH oxidase involved in the early stages of hematopoietic differentiation from human induced pluripotent stem cells
- 1 January 2020
- journal article
- research article
- Published by Elsevier BV in Free Radical Biology & Medicine
- Vol. 146, 107-118
- https://doi.org/10.1016/j.freeradbiomed.2019.10.005
Abstract
No abstract availableFunding Information
- Interreg
- Université Grenoble Alpes
This publication has 94 references indexed in Scilit:
- Derivation and Functional Analysis of Patient-Specific Induced Pluripotent Stem Cells as an In Vitro Model of Chronic Granulomatous DiseaseThe International Journal of Cell Cloning, 2012
- The promise of induced pluripotent stem cells in research and therapyNature, 2012
- Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cellsNature Protocols, 2011
- Hematopoietic Development from Human Induced Pluripotent Stem CellsAnnals of the New York Academy of Sciences, 2009
- Redox Regulation of Stem and Progenitor CellsAntioxidants and Redox Signaling, 2008
- TSC–mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen speciesThe Journal of Experimental Medicine, 2008
- Identification of a Hierarchy of Multipotent Hematopoietic Progenitors in Human Cord BloodCell Stem Cell, 2007
- A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic nicheBlood, 2007
- NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generationBiochemical Journal, 2007
- The NADPH Oxidase NOX4 Drives Cardiac Differentiation: Role in Regulating Cardiac Transcription Factors and MAP Kinase ActivationMolecular Biology of the Cell, 2006